Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of benzenesulfonamides, characterized by a thiophene core substituted with a cyanophenyl group and a sulfonamide moiety. It has been cataloged as an experimental compound in chemical and drug databases but does not have an established therapeutic use or approved indication. Its mechanism of action, biological targets, and pharmacological properties are not described in public sources. The compound is referenced in structural biology as ligand CCT (PDB code: 2d3u), indicating it has been used for protein-ligand studies[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 5-(4-cyanophenyl)-3-{[(2-methylphenyl)sulfonyl]amino}thiophene-2-carboxylic acid.